GLP-1 Weight Loss in Portland, Maine: An Urban Island in a Rural State, and a Cash Market That Won't Quote a Total
Portland's 5.5-point gap under Maine's rate, rural Cumberland County HPSAs that stop at the city line, Maine Medical Center's specialist concentration, and one local price that is not a total.
Portland's adult obesity prevalence is 27.7% (CDC PLACES 2025 release, BRFSS 2023) 1, running 5.5 points below Maine's statewide 33.2% 2. The state's obesity burden is real; Portland is not where it concentrates.
This is a city of 69,572 inside a 562,843-person metro, 4.4% uninsured, with an $82,059 median household income 34. The gap here is not coverage or supply. It is that of three Portland providers checked, exactly one publishes any number, and even that one is not a total 891011.
Portland itself carries no general-population Primary Care HPSA designation — the city as a whole is not a federally designated shortage area. Its only active HPSA is facility-specific: Portland Community Health Center, the city's FQHC safety-net clinic, is designated (score 10, estimated 22,211 patients served), meaning the access gap HRSA recognizes is concentrated among the low-income/uninsured population that clinic serves, not the general public. By contrast, the rest of Cumberland County genuinely is shortage-designated: Sebago Lake SA (geographic HPSA, score 11), Porter SA (score 10), and LI-Fryeburg SA (score 16) are all active Primary Care HPSAs — but all sit in the rural western part of the county, not in Portland proper. Source: HRSA Primary Care HPSA bulk file (BCD_HPSA_FCT_DET_PC.csv), data.hrsa.gov, pulled Aug 28, 2026.5
Specialist access
Portland hosts Maine's deepest specialist infrastructure: Maine Medical Center's Portland campus is the state's only Level I Trauma Center and provides tertiary-level care (MaineHealth) — the best in-person specialist-access city in Maine by a wide margin. HRSA's shortage-designation program does not score endocrinology or obesity-medicine access at all (only primary care, dental, and mental health are scored), so there is no numeric specialist-shortage figure for Portland specifically; the verifiable fact is qualitative — Portland is where Maine's tertiary/specialist care concentrates, while the rural HPSA-flagged parts of the state (see hpsaSummary) have essentially none.6
Medicaid coverage note
Maine expanded MaineCare (Medicaid) eligibility via a November 2017 voter-approved ballot initiative; implementation began January 10, 2019, with coverage retroactive to July 2018 (KFF Medicaid expansion tracker). Whether a specific MaineCare or commercial plan covers a GLP-1 medication for weight loss (as opposed to a diabetes diagnosis) depends on the individual plan and formulary. This is a general state benefit-design pattern, not a Portland-specific figure — no single MaineCare pharmacy/formulary policy citation was located to pin the weight-loss-specific answer down further, so that detail is left as an honest data gap rather than a guess.7
MaineCare expanded in 2019, but the weight-loss answer is plan by plan
Maine expanded MaineCare through a November 2017 voter-approved ballot initiative, with implementation beginning January 10, 2019 and coverage retroactive to July 2018 7.
Whether a specific MaineCare or commercial plan covers a GLP-1 for weight loss, as opposed to a diabetes diagnosis, depends on the individual plan and formulary. No single MaineCare pharmacy or formulary citation was located to pin the weight-loss answer down, so that detail is left here as a data gap rather than a guess.
What GLP-1 care costs in Portland today
The Cosmetic Enhancement Center of New England at 1945 Congress St, Building C publishes a membership structure: a $300 one-time enrollment fee plus $150/month covering injection visits, with medication billed separately and described only as varying by dosage 8. A separate page on the same site quotes semaglutide "starting at $450 per month with a 3-month commitment" 9. That is a starting price on top of a membership, before a variable medication cost, and it is the only published number in the city.
Maine Aesthetic Medicine at 163 Fore Street says on its homepage that its weight-loss and GLP-1 program is "launching in 2026" and directs patients to contact the practice for an "exclusive discount" quote; there is no dedicated GLP-1 page and no dollar figure anywhere in its navigation 10. Glad Health at 278 Veranda St, a concierge practice, offers a weight-management membership with "first month free" language and names no GLP-1 drug and no price 11.
Astra's price is published and flat everywhere it treats: $68/month for compounded semaglutide and $118/month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416. That is the same number in Portland as in every other state Astra serves, with no local rate and no consult required to see it.
Maine's specialist center, ringed by shortage areas it doesn't share
Portland itself carries no general-population Primary Care HPSA. Its only active designation is facility-specific: Portland Community Health Center, the city's FQHC, is designated at score 10 with an estimated 22,211 patients served, so the gap HRSA recognizes here belongs to that clinic's low-income panel rather than the general public 5.
The rest of Cumberland County is a different story. Sebago Lake SA (geographic, score 11), Porter SA (score 10), and LI-Fryeburg SA (score 16) are all active Primary Care HPSAs, and all sit in the rural western part of the county rather than in Portland 5. Maine Medical Center's Portland campus is the state's only Level I Trauma Center and its tertiary-care hub 6, which makes Portland the best in-person specialist city in Maine by a wide margin and leaves the rest of the state driving to it.
HRSA scores only primary care, dental, and mental health, so there is no numeric endocrinology figure for Portland. Telehealth matters here less for the city than for the county around it: an online visit does not require the drive into Portland. Astra serves all 50 states, including Maine.
Astra treats patients in Maine through state-licensed physicians.
Local options
Cosmetic Enhancement Center of New England — Portland (1945 Congress St, Building C, Portland, ME 04102) — Publishes a weight-loss membership structure: $300 one-time enrollment fee + $150/month membership fee (covers injection visits), with medication cost billed separately and described only as varying by dosage — confirmed verbatim on this page. A separate page on the same site (see sources: 'CEC of New England — Weight Loss') quotes semaglutide 'starting at $450 per month with a 3-month commitment' — a starting price, not a guaranteed all-in total, and before that variable medication cost is added. This is the only Portland provider found with any published number, and even it isn't a guaranteed total. https://www.cecofne.com/weight-loss/glp1-medications/(checked 2026-08-28)
Maine Aesthetic Medicine (163 Fore Street, Floor 2, Portland, ME 04101) — Homepage states its weight-loss and GLP-1 program is 'launching in 2026' and directs interested patients to contact the practice for an 'exclusive discount' quote; no dedicated weight-loss/GLP-1 page and no dollar price exists anywhere in the site's navigation. Checked specifically to confirm market opacity, not to source a number. https://maineaestheticmedicine.com/(checked 2026-08-28)
Glad Health (278 Veranda St, Portland, ME 04103) — Concierge/functional-medicine practice offering a weight-management membership (DietDoctor partnership, 'first month free' language); no semaglutide/tirzepatide brand name or dollar price is published anywhere on the site. https://www.gladhealth.com/individual-plans(checked 2026-08-28)
Frequently asked questions
Is Astra cheaper than other GLP-1 care in Portland, Maine?
Astra's national price is $68/mo for semaglutide and $118/mo for tirzepatide on a 12-month plan ($816/$1,416 billed annually) — the same price in every city, every dose. In Portland, cash-pay pricing is largely undisclosed: of three local providers checked, only Cosmetic Enhancement Center of New England publishes a number — a $300 enrollment plus $150/month membership, with semaglutide 'starting at $450/month' before its variable medication cost is even added. Maine Aesthetic Medicine and Glad Health publish no price at all. Against that opacity, Astra's flat $68/$118 is the one fixed, published number in the Portland market.
Is Portland, Maine considered a medically underserved area?
Not as a whole city. Portland carries no general Primary Care HPSA designation — its only HRSA flag is facility-specific, at Portland Community Health Center (score 10, ~22,211 patients served). The genuine shortage areas — Sebago Lake, Porter, and LI-Fryeburg service areas — sit in the rural western part of Cumberland County, not downtown Portland.
Does MaineCare (Medicaid) cover GLP-1 weight-loss drugs like Ozempic or Wegovy?
Maine adopted Medicaid expansion by ballot initiative in November 2017, effective January 10, 2019 (KFF). Whether MaineCare or a commercial plan covers a GLP-1 specifically for weight loss (versus a diabetes diagnosis) depends on the individual plan — there's no single statewide answer and no Portland-specific coverage figure. Astra's flat $68/mo (semaglutide) and $118/mo (tirzepatide) national pricing is designed to work as a self-pay option regardless of what a given plan covers.
Where can you get tirzepatide (Zepbound/Mounjaro) in Portland, ME?
Locally, Cosmetic Enhancement Center of New England, Maine Aesthetic Medicine (launching 2026), and Glad Health all offer weight-management services in Portland, though none publish a guaranteed all-in tirzepatide price. Astra offers tirzepatide by telehealth at a flat $118/mo on a 12-month plan, available to Portland residents since Astra is licensed in all 50 states.
Is obesity more common in Portland or in the rest of Maine?
The rest of Maine. Portland's crude adult obesity prevalence is 27.7% (2023 BRFSS cycle, CDC PLACES) versus Maine's statewide rate of 33.2% (2024 BRFSS) — about 5.5 points lower in the city. CDC PLACES doesn't publish a county-level figure, but the gap is consistent with the state's obesity burden concentrating outside Portland, including the same rural stretches of Cumberland County that HRSA separately flags as primary-care shortage areas.